Keyphrases
Pancreatic Cancer
100%
18F-fluorodeoxyglucose (18F-FDG)
100%
SUVmax
100%
Fluorodeoxyglucose Uptake
100%
Response to Chemoradiotherapy
100%
Induction Chemotherapy
66%
Tumor
50%
Overall Survival
50%
Partial Response
50%
Chemoradiotherapy
50%
Cancer Patients
33%
Multivariate Analysis
33%
Response Rate
33%
Therapeutic Response
33%
18F-fluorodeoxyglucose PET
33%
Optimal Cutoff
16%
Initial Diagnosis
16%
Stable Disease
16%
Surgical Resection
16%
Standardized Uptake Value
16%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
16%
Progressive Disease
16%
Glycolysis
16%
Glucose Uptake
16%
Metabolic Shift
16%
Borderline Resectable
16%
Radioresistance
16%
Tumor Response Rate
16%
Medicine and Dentistry
Pancreas Cancer
100%
Fluorodeoxyglucose F 18
100%
Chemoradiotherapy
100%
Neoplasm
66%
Induction Chemotherapy
66%
Overall Survival
50%
Multivariate Analysis
33%
Fluorodeoxyglucose
33%
Treatment Response
33%
Positron Emission Tomography
33%
Disease
16%
Surgery
16%
Positron Emission Tomography
16%
Standardized Uptake Value
16%
Progressive Disease
16%
Radiosensitivity
16%
Glucose Uptake
16%
Immunology and Microbiology
Overall Survival
100%
Radioresistance
33%
Positron Emission Tomography
33%
Glucose Transport
33%